GSK-126
Kurzübersicht für GSK-126 (ABIN7233255)
Applikation
Chemical Name
-
-
Verwendungszweck
- EZH2 Histone methyltransferase inhibitor
-
Produktmerkmale
- Competitive, selective inhibitor of H3K27 methyltransferase EZH2 (Ki = 0.57 nM), over EZH1 (Ki = 89 nM) and other histone methyltransferases (Ki > 1 μM). GSK-126 caused a dose-dependent decrease in H3K27me3, and blocked invasion of triple-negative breast cancer cells. Conversely, it induced myeloid-derived suppressor cells, blocking antitumor immunity in mice. Decreases myeloma CSCs4, while also inducing differentiation of HepaRG hepatic progenitor cells5. Used to explore the role of epigenetic modification in a mouse model of Parkinson's disease.
-
Reinheit
- >98 %
-
Formel
- C31H38N6O2
-
Löslichkeit
- Soluble in DMSO (up to 15 mg/ml) or in Ethanol (up to 2 mg/ml).
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Powder
-
Lagerung
- -20 °C
-
-
-
Hintergrund
- GSK-2816126,Cell migration,Epigenetics,Transcription,Protein methyltransferase,Stem cells,Cancer stem cells,Ubiquitin/Proteasome,Inflammation,Cancer,Neurodegeneration,Posttranslational modification,Pain,Chromatin
-
Molekulargewicht
- 526.7
-
CAS-Nummer
- 1346574-57-9
-
-